心臟房間分流裝置市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球心房分流裝置市場價值為 38 億美元，預計 2025 年至 2034 年期間的複合年成長率為 7%。該程序有助於調節血流和緩解壓力不平衡，特別是對於患有某些心血管疾病的患者。透過最佳化血流，這些設備可以提高心臟效率並改善心臟相關問題患者的生活品質。

心臟房間分流裝置的需求不斷增加，很大程度上是由於醫療技術的不斷進步所推動的。製造商不斷改進設備設計，利用更好的材料，改進植入技術，以實現更安全、更有效的治療。這些創新提高了設備性能，最終增強了醫生信心並提高了採用率。隨著支持使用這些設備的臨床證據不斷增加，市場潛力仍然廣闊，特別是對於患有心臟衰竭和肺動脈高壓等疾病的患者。

心房間分流裝置市場的產品類型主要分為球囊擴張裝置、自擴張裝置和其他裝置。其中，球囊擴張裝置佔據市場主導地位，預計 2024 年的收入佔有率為 21 億美元。人們期待它們繼續取得成功，因為它們在治療一系列心臟疾病方面仍然非常有效，並且在未來幾年顯示出巨大的成長潛力。

在應用方面，市場中最大的佔有率屬於心臟衰竭管理，到 2024 年將佔據約 68.9% 的市場佔有率。心臟房間分流裝置透過降低左心房壓力和改善 HFpEF 患者的症狀在這一領域發揮著至關重要的作用。此功能解決了心臟衰竭護理中尚未滿足的重大需求，使這些設備成為現代心臟治療的寶貴工具。

在美國，心臟房間分流裝置市場規模將在 2024 年達到 11 億美元，並有望顯著成長。美國憑藉其先進的醫療基礎設施、較高的心血管疾病發病率以及蓬勃發展的研發部門，在該市場處於領先地位。這些因素，加上對醫療技術的大量投入，加速了醫院對心臟房間分流裝置的創新和廣泛使用，促進了市場在全國範圍內的擴張。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 心臟衰竭盛行率上升
    • 技術進步
    • 微創手術的採用日益廣泛
    • 老年人口基數不斷擴大
  • 產業陷阱與挑戰
    • 替代療法的可用性
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 重要新聞和舉措
• 差距分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

• 主要趨勢
• 球囊擴張裝置
• 自膨脹裝置
• 其他產品類型

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 心臟衰竭管理
• 肺動脈高壓治療
• 其他應用

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 專科診所
• 其他最終用途

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Adona Medical
• Alleviant Medical
• BioVentrix
• Corvia Medical
• CryoLife
• Edwards Lifesciences
• Gore Medical
• InterShunt Technologies
• Johnson & Johnson
• Lepu Medical
• Medtronic
• Micro Interventional Devices
• Occlutech
• Venus Medtech
• Wuhan Weike Medical Technology

The Global Interatrial Shunt Devices Market was valued at USD 3.8 billion in 2024 and is set to grow at a CAGR of 7% from 2025 to 2034. Interatrial shunt devices are innovative medical technologies designed to create a controlled passage between the heart's left and right atria. This procedure helps regulate blood flow and alleviate pressure imbalances, particularly in patients suffering from certain cardiovascular conditions. By optimizing blood flow, these devices can enhance cardiac efficiency and improve the quality of life for individuals with heart-related issues.

The increasing demand for interatrial shunt devices is largely driven by the ongoing advancements in medical technology. Manufacturers are continuously improving device designs, utilizing better materials, and refining implantation techniques, which have led to safer and more effective treatments. These innovations have translated into enhanced device performance, ultimately boosting physician confidence and driving higher adoption rates. As clinical evidence supporting the use of these devices continues to grow, the market's potential remains expansive, particularly for patients with conditions like heart failure and pulmonary hypertension.

Product types in the interatrial shunt devices market are mainly categorized into balloon-expandable devices, self-expanding devices, and others. Among these, balloon-expandable devices are leading the market with an estimated revenue share of USD 2.1 billion in 2024. This segment's dominance is attributed to the devices' ease of deployment, precise positioning, and overall clinical advantages. Their continued success is expected, as they remain highly effective in treating a range of heart conditions and demonstrate significant growth potential in the coming years.

In terms of applications, the largest share of the market belongs to heart failure management, accounting for approximately 68.9% of the market in 2024. This segment is anticipated to continue its upward trajectory, fueled by the increasing prevalence of heart failure with preserved ejection fraction (HFpEF). Interatrial shunt devices play a crucial role in this area by reducing left atrial pressure and improving symptoms in HFpEF patients. This functionality addresses a significant unmet need in heart failure care, making these devices a valuable tool in modern cardiac treatments.

In the United States, the interatrial shunt devices market reached USD 1.1 billion in 2024 and is poised for notable growth. The U.S. stands as a leader in this market due to its advanced healthcare infrastructure, high incidence of cardiovascular diseases, and a thriving research and development sector. These factors, combined with substantial investments in medical technologies, have accelerated the innovation and widespread use of interatrial shunt devices in hospitals, contributing to the market's expansion across the country.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of heart failure
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Growing adoption of minimally invasive procedures
    • 3.2.1.4 Expanding geriatric population base
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of alternative treatments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Key news and initiatives
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Balloon expandable devices
• 5.3 Self-expanding devices
• 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Heart failure management
• 6.3 Pulmonary hypertension treatment
• 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Specialty clinics
• 7.5 Other End Use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Adona Medical
• 9.2 Alleviant Medical
• 9.3 BioVentrix
• 9.4 Corvia Medical
• 9.5 CryoLife
• 9.6 Edwards Lifesciences
• 9.7 Gore Medical
• 9.8 InterShunt Technologies
• 9.9 Johnson & Johnson
• 9.10 Lepu Medical
• 9.11 Medtronic
• 9.12 Micro Interventional Devices
• 9.13 Occlutech
• 9.14 Venus Medtech
• 9.15 Wuhan Weike Medical Technology